Importance of endogenous adenosine during ischemia and reperfusion in neonatal porcine hearts

Circulation

Volumn 96, Issue 9, 1997, Pages 3094-3103

  Sommerschild, Hilchen T ^a   Grund, Frank ^a   Offstad, Jon ^a   Jynge, Per ^c   Ilebekk, Arnfinn ^a   Kirkebøen, Knut A ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c Medical Technical Center   (Norway)

Author keywords

Adenosine; Infarction; Ischemia; Myocardium; Reperfusion

Indexed keywords

ADENOSINE; ADENOSINE RECEPTOR BLOCKING AGENT; DRAFLAZINE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; ISOLATED HEART; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PURINE METABOLISM; REPERFUSION INJURY; SWINE;

EID: 0030685739     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.9.3094     Document Type: Article

References (63)

1. Hori M, Kitakaze M. Adenosine, the heart, and coronary circulation. Hypertension. 1991;18:565-574.
2. Babitt DG, Virmani R, Forman MB. Intracoronary adenosine administered after reperfusion limits vascular injury after prolonged ischemia in the canine model. Circulation. 1989;80: 1388-1399.
3. Sekili S, Jeroudi O, Tang X-L, Zughaib M, Sun J-Z, Bolli R. Effect of adenosine on myocardial 'stunning' in the dog. Circ Res. 1995; 1388-1399.
4. Finegan BA, Lopaschuk GD, Coulson CS, Clanahan AS. Adenosine alters glucose use during ischemia and reperfusion in isolated rat hearts. Circulation. 1993;87:900-908.
5. Downey JM, Liu GS, Thornton JD. Adenosine and the anti-infarct effects of preconditioning. Cardiovasc Res. 1993;27:3-8.
6. Kroll K, Kelm KMM, Buring K-F, Schrader J. Transendothelial transport and metabolism of adenosine and inosme in the intact rat aorta. Circ Res. 1989;64:1147-1157.
7. Bullough DA, Magill MJ, Mullane KM. Compartmentation of cardiac adenosine: importance of intravascular adenosine for cardioprotection. Circulation. 1995;92(suppl I):I-523.
8. Delyani JA, Van Wylen DGL. Endocardial and epicardial interstitial purines and lactate during graded ischemia. Am J Physiol. 1994;266:H1019-H1026.
9. Van Belle H. Nucleoside transport inhibition: a therapeutic approach to cardioprotection via adenosine? Cardiovasc Res. 1993; 27:68-76.
10. ATP channels. Am J Physiol. 1995;268:H2294-H2301.
11. Minamino T, Kitakaze M, Morioka T, Node K, Shinozaki Y, Chujo M, Mori H, Takeda H, Inoue M, Hori M, Kamada T. Bidirectional effects of aminophylline on myocardial ischemia. Circulation. 1995; 92:1254-1260.
12. Angello DA, Headrick JP, Coddington NM, Berne RM. Adenosine antagonism decreases metabolic but not functional recovery from ischemia. Am J Physiol. 1991;260:H193-H200.
13. Offstad J, Kirkebøen KA, Ilebekk A, Downing SE. ATP-gated potassium channels in acute hibernation and reperfusion. Cardiovasc Res. 1994;28:872-880.
14. Gao Z-P, Downey HF, Fan W-L, Mallet RT. Does interstitial adenosine mediate acute hibernation of guinea pig myocardium? Cardiovasc Res. 1995;29:796-804.
15. Lasley RD, Mentzer RM Jr. Adenosine increases lactate release and delays onset of contracture during global low flow ischaemia. Cardiovasc Res. 1993;27:96-101.
16. Rynning SE, Brunvand H, Birkeland S, Hexeberg E, Grong K. Endogenous adenosine attenuates myocardial stunning by antiadrenergic effects exerted during ischemia and not during reperfusion. J Cardiovasc Pharmacol. 1995;25:432-439.
17. Bunch FT, Thornton J, Cohen MV, Downey JM. Adenosine is an endogenous protectant against stunning during repetitive ischemic episodes in the heart. Am Heart J. 1992;124:1440-1445.
18. Auchampach JA, Gross GJ. Adenosine A1 receptors KATP channels, and ischemic preconditioning in dogs. Am J Physiol. 1993; 264:H1327-H1336.
19. 1 adenosine receptors in rabbit heart. Circulation. 1991;84:350-356.
20. Liu G, Richards SC, Olsson RA, Mullane K, Walsh RS, Downey JM. Evidence that the adenosine A3 receptor may mediate the protection afforded by preconditioning in the isolated rabbit heart. Cardiovasc Res. 1994;28:1057-1061.
21. Zhao ZQ, McGee S, Nakanishi K, Toombs CF, Johnston WE, Ashar MS, Vinten-Johansen J. Receptor-mediated cardioprotective effects of endogenous adenosine are exerted primarily during reperfusion after coronary occlusion in the rabbit. Circulation. 1993;88:709-719.
22. Toombs CF, McGee DS, Johnston WE, Vinten-Johansen J. Myocardial protective effects of adenosine: infarct size reduction with pretreatment and continued receptor stimulation during ischemia. Circulation. 1992;86:986-994.
23. Hammon JW Jr. Myocardial protection in the immature heart. Ann Thorac Surg. 1995;60:839-842.
24. Wegelin I, Pane G, Finelli C, Clo C, Zanfanti ML. Age-related changes of AMP breakdown in chicken heart. Comp Biochem Physiol. 1995;110A:27-31.
25. Matherne GP, Ely SW, Headrick JP. Maturational differences in bioenergetic state and purine formation during 'supply' and 'demand' ischemia. J Mol Cell Cardiol. 1996;28:1143-1155.
26. Pridjian AK, Bove EL, Bolling SF, Childs KF, Brosamer KS, Lupinetti FM. Developmental differences in myocardial protection in response to 5-nucleotidase inhibition. J Thorac Cardiovasc Surg. 1994;107:520-526.
27. Daly JW, Padgett W, Shamim MT, Butts-Lamb P, Waters J. 1,3-Dialkyl-8-(p-sulfophenyl)xanthines: potent water-soluble antagonists for A1 and A2-adenosine receptors. J Med Chem. 1985;28: 487-492
28. Martin BJ, Lasley RD, Noble MA, Hegge JO, Mentzer RM Jr. Nucleoside transport inhibition with R75231 augments endogenous adenosine concentrations and reduces infarct size in swine. Circulation. 1995;92(suppl I):I-523.
29. Martin BJ, Lasley RD, Mentzer RM Jr. Infarct size reduction with the nucleoside transport inhibitor R-75231 in swine. Am J Physiol. 1997;272:H1857-H1865.
30. Poucher SM, Brooks R, Pleeth RM, Conant AR, Collis MG. Myocardial infarction and purine transport inhibition m anaesthetised ferrets. Eur J Pharmacol. 1994;252:19-27.
31. Sandhu GS, Burrier AC, Janero DR. Adenosine deaminase inhibitors attenuate ischemic injury and preserve energy balance in isolated guinea pig heart. Am J Physiol. 1993;265:H1249-H1256
32. Masuda M, Demeulemeester A, Chang-Chun C, Hendrikx M, Van Belle H, Flameng W. Cardioprotective effects of nucleoside transport inhibition in rabbit hearts: a role of endogenous adenosine. Ann Thorac Surg. 1991;52:1300-1305.
33. Van Belle H, Goossens F, Wynants J. Biochemical and functional effects of nucleoside transport inhibition in the isolated cat heart. J Mol Cell Cardiol. 1989;21:797-805.
34. Zughaib ME, Abd-Elfattah AS, Jeroudi MO, Sun J-Z, Sekih S, Tang X-L, Bolli R. Augmentation of endogenous adenosine attenuates myocardial 'stunning' independently of coronary flow or hemodynamic effects. Circulation. 1993;88:2359-2369.
35. Itoya M, Miura T, Sakamoto J, Urabe K, Iimura O. Nucleoside transport inhibitors enhance the infarct size-limiting effect of ischemie preconditioning. J Cardiovasc Pharmacol. 1994;24:846-852.
36. Silva PH, Dillon D, Van Wylen DGL. Adenosine deaminase inhibition augments interstitial adenosine but does not attenuate myocardial infarction. Cardiovasc Res. 1995;29:616-623.
37. Galinanes M, Qiu Y, Van Belle H, Hearse DJ. Metabolic and functional effects of the nucleoside transport inhibitor R75231 in the ischaemic and blood reperfused myocardium. Cardiovasc Res. 1993;27:90-95.
38. Triana JF, Li X-Y, Jamaluddin U, Thornby JI, Bolli R. Postischemic myocardial 'stunning': identification of major differences between open chest and the conscious dog and evaluation of the oxygen radical hypothesis in the conscious dog. Circ Res. 1991;69: 731-747.
39. Van Belle H, Ver Donck K, Verheyen W. Role of nucleoside transport inhibition and endogenous adenosine in prevention of catecholamine induced death in rabbits. Cardiovasc Res. 1993;27: 111-115.
40. Downing SE, Chen V. Acute hibernation and reperfusion of the ischemic heart. Circulation. 1992;85:699-707.
41. Eisenhauer CL, Matsuda LS, Uyehara CFT. Normal physiologic values of neonatal pigs and the effects of isoflurane and pentobarbital anesthesia. Lab Anim Sci. 1994;44:245-252.
42. Rosenberg JC, Rush BF. An enzymatic spectrophotometric determination of pyruvic and lactic acid in blood. Clin Chem. 1966;12: 299-307.
43. Lowry OH, Passonneau JV. A Flexible System of Enzymatic Analysis. New York, NY: Academic Press; 1972:147-217.
44. Sellevold OFM, Jynge P, Aarstad K. High performance liquid chromatography: a rapid isocratic method for determination of creatine compounds and adenine nucleotides in myocardial tissue. J Mol Cell Cardiol. 1986;18:517-527.
45. Van Belle H, Janssen PAJ. Comparative pharmacology of nucleoside transport inhibitors. Nucleosides Nucleotides. 1991;10: 975-982.
46. Offstad J, Kirkebøen KA, Sommerschild HT, Ilebekk A, Downing SE. Repetitive stretching during myocardial low-flow ischemia impairs contractile function in isolated piglet hearts. J Mol Cell Cardiol. 1995;27:A181. Abstract.
47. Janier MF, Vanoverschelde J-LJ, Bergmann SR. Adenosine protects ischemic and reperfused myocardium by receptor-mediated mechanisms. Am J Physiol. 1993;264:H163-H170.
48. Lasley RD, Mentzer RM Jr. Adenosine improves recovery of post-ischemic myocardial function via an adenosine A1 receptor mechanism. Am J Physiol. 1992;263:H1460-H1465.
49. Fralix TA, Murphy E, London RE, Steenbergen C. Protective effects of adenosine in the perfused rat heart: changes in metabolism and intracellular ion homeostasis. Am J Physiol. 1993;264: C986-C994.
50. i in energy deprivation contracture. Circ Res. 1987;61:726-734.
51. Lopaschuk GD, Collins-Nakai RL, Itoi T. Developmental changes in energy substrate use by the heart. Cardiovasc Res. 1992;26: 1172-1180.
52. McClanahan TB, Ignasiak DP, Martin BJ, Mertz TE, Gallagher KP. Effect of adenosine deaminase inhibition with pentostatin on myocardial stunning in dogs. Basic Res Cardiol. 1995;90:176-183.
53. Dorheim TA, Hoffman A, Van Wylen DGL, Mentzer RM Jr. Enhanced interstitial fluid adenosine attenuates myocardial stunning. Surgery. 1991;110:136-145.
54. Kirkebøen KA, Ilebekk A, Tønnessen T, Leistad E, Næss PA, Christensen G, Aksnes G. Cardiac contractile function following repetitive brief ischemia: effects of nucleoside transport inhibition. Am J Physiol. 1994;36:H57-H65.
55. Abd-Elfattah AS, Ding M, Dyke CM, Wechsler AS. Protection of the stunned myocardium: selective nucleoside transport blocker administered after 20 minutes of ischemia augments recovery of ventricular function. Circulation. 1993;88(pt 2):II-336-II-343.
56. Abd-Elfattah AS, Jessen ME, Wechsler AS. Nucleoside trapping during reperfusion prevents ventricular dysfunction, 'stunning,' in absence of adenosine. J Thorac Cardiovasc Surg. 1994;108: 269-278.
57. Abd-Elfattah AS, Jessen ME, Hanan SA, Tuchy G, Wechsler AS. Is adenosine 5′-triphosphate derangement or free-radical-mediated injury the major cause of ventricular dysfunction during reperfusion? Role of adenine nucleoside transport in myocardial reperfusion injury. Circulation. 1990;82(suppl IV):IV-341-IV-350.
58. Gidday JM, Fitzgibbons JC, Shah AR, Kraujalis MJ, Park TS. Reduction in cerebral ischemic injury in the newborn rat by potentiation of endogenous adenosine. Pediatr Res. 1995;38:306-311.
59. Pelleg A, Belardinelli L. Cardiac electrophysiology and pharmacology of adenosine: basic and clinical aspects. Cardiovasc Res. 1993;27:54-61.
60. de Jong JW, van der Meer P, Nieukoop AS, Huizer T, Stroeve RJ, Bos E. Xanthine oxidoreductase activity in perfused hearts of various species, including humans. Circ Res. 1990;67:770-773.
61. Wyatt DA, Edmunds MC, Rubio R, Berne RM, Lasley RD, Mentzer RM Jr. Adenosine stimulates glycolytic flux in isolated perfused rat hearts by A1-adenosine receptors. Am J Physiol. 1989; 257:H1952-H1957.
62. + channels to A1 receptors by G proteins in rat ventricular myocytes. Am J Physiol. 1990;259:H820-H826.
63. Neely JR, Grotyohann LW. Role of glycolytic products in damage to ischemic myocardium: dissociation between adenosine triphosphate levels and recovery of function of reperfused ischemic hearts. Circ Res. 1984;55:816-824.